Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.54 EUR | +0.42% |
|
-2.01% | -10.13% |
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.78 for the current period. Therefore, the company is undervalued.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.13% | 842.58Cr | - | ||
-4.65% | 137.65Cr | D | ||
-13.34% | 127.75Cr | B+ | ||
-5.79% | 120.05Cr | - | ||
-26.51% | 77Cr | - | - | |
-.--% | 62Cr | - | - | |
+3.68% | 47Cr | - | ||
+2.04% | 43Cr | - | - | |
-31.93% | 30Cr | - | - | |
-62.49% | 27Cr | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.